Published in Cancer Prev Res (Phila) on May 02, 2016
Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment. Mol Med Rep (2016) 0.75
Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer. Sci Rep (2017) 0.75
Therapeutic Role of Functional Components in Alliums for Preventive Chronic Disease in Human Being. Evid Based Complement Alternat Med (2017) 0.75
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Signaling to NF-kappaB. Genes Dev (2004) 19.78
Nuclear factor-kappaB in cancer development and progression. Nature (2006) 18.31
Missing pieces in the NF-kappaB puzzle. Cell (2002) 17.83
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature (2000) 8.37
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell (1974) 6.18
NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell (2007) 4.56
Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell (2007) 4.39
The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer (2013) 4.20
A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci (2003) 3.79
Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res (1994) 2.84
Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol (2012) 2.73
Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am J Epidemiol (1994) 2.72
Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (2010) 2.55
NF-kappaB in inflammatory bowel disease. J Intern Med (2008) 2.21
Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim (1999) 2.20
Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis (2013) 2.02
Clarifying the real bioactive constituents of garlic. J Nutr (2006) 1.88
NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J (1999) 1.87
Growth factor production by human colon carcinoma cell lines. Cancer Res (1989) 1.82
Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Cancer Res (1987) 1.61
Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. J Biol Chem (2003) 1.57
The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res (2008) 1.43
Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci (2007) 1.40
Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine (2010) 1.36
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res (2005) 1.17
Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol (2014) 1.16
Inhibitory kappa B Kinases as targets for pharmacological regulation. Br J Pharmacol (2012) 1.14
Pathology of rodent models of intestinal cancer: progress report and recommendations. Gastroenterology (2013) 1.12
Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography. Neoplasia (2009) 1.11
Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am J Clin Nutr (2007) 1.10
Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. Br J Cancer (2009) 1.08
Functional components and medicinal properties of food: a review. J Food Sci Technol (2014) 1.07
Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors. Cancer Res (2012) 1.06
Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol (2006) 1.06
Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis (1987) 1.05
The role of inflammation in colon cancer. Adv Exp Med Biol (2014) 1.01
Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol (2014) 1.00
The immunomodulation and anti-inflammatory effects of garlic organosulfur compounds in cancer chemoprevention. Anticancer Agents Med Chem (2014) 0.95
Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Res (2013) 0.95
Targeting the NF-κB pathway in cancer therapy. Surg Oncol Clin N Am (2013) 0.92
Diallyl disulfide suppresses the growth of human colon tumor cell xenografts in athymic nude mice. J Nutr (1996) 0.86
Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol (2014) 0.86
NF-κB in cellular senescence and cancer treatment. Mol Cells (2014) 0.85
Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Mol Carcinog (2014) 0.83
[Inhibitory effect of diallyl disulfide on proliferation of human colon cancer cell line SW480 in nude mice]. Ai Zheng (2007) 0.79
Orally administered allyl sulfides from garlic ameliorate murine colitis. Mol Nutr Food Res (2015) 0.79
Diet-based strategies for cancer chemoprevention: the role of combination regimens using dietary bioactive components. Annu Rev Food Sci Technol (2015) 0.78
LIVER DAMAGE AND SENESCENCE INCREASES IN PATIENTS DEVELOPING HEPATOCELLULAR CARCINOMA. J Gastroenterol Hepatol (2017) 0.75